Category Business

AbbVie and ADARx Pharmaceuticals Forge Collaboration and Licensing Deal to Advance Next-Gen siRNA Therapies Across Diverse Disease Areas

AbbVie and ADARx Partner to Advance Next-Generation siRNA Therapies Across Neuroscience, Immunology, and Oncology in Multibillion-Dollar Collaboration AbbVie, a global biopharmaceutical leader known for its portfolio of therapies in immunology, oncology, neuroscience, and other specialty areas, has announced a significant…

Read MoreAbbVie and ADARx Pharmaceuticals Forge Collaboration and Licensing Deal to Advance Next-Gen siRNA Therapies Across Diverse Disease Areas
Innate

Innate Pharma Announces First Quarter 2025 Financial Results and Business Highlights

Innate Pharma Announces First Quarter 2025 Financial Results and Business Highlights Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA), a clinical-stage oncology-focused biotechnology company pioneering innovative immunotherapies, announced its consolidated financial results for the first quarter ending March 31, 2025,…

Read MoreInnate Pharma Announces First Quarter 2025 Financial Results and Business Highlights

Sanofi Highlights Scientific Leadership and Innovation in Chronic Inflammatory Respiratory Diseases at ATS

Sanofi Showcases Expansive Respiratory Innovation and Scientific Leadership at ATS 2025 with Robust Clinical Data from Dupixent and Immunology Pipeline Sanofi is poised to make a major impact at the 2025 American Thoracic Society (ATS) International Conference, taking place from…

Read MoreSanofi Highlights Scientific Leadership and Innovation in Chronic Inflammatory Respiratory Diseases at ATS
, PCI Pharma

PCI Pharma Acquires Ajinomoto Althea as Part of $1B Investment to Boost U.S. Aseptic Fill-Finish Capacity

PCI Pharma Acquires Ajinomoto Althea as Part of $1B Investment to Boost U.S. Aseptic Fill-Finish Capacity PCI Pharma Services, a globally recognized contract development and manufacturing organization (CDMO) specializing in the development and commercialization of innovative biopharmaceutical therapies, has officially…

Read MorePCI Pharma Acquires Ajinomoto Althea as Part of $1B Investment to Boost U.S. Aseptic Fill-Finish Capacity
Sunflower Therapeutics

Sunflower Therapeutics Announces Sales Agreement with Optimal Biotech Group

Sunflower Therapeutics Announces Sales Agreement with Optimal Biotech Group Sunflower Therapeutics, a public benefit corporation with a mission to transform global access to protein manufacturing capacity, has taken a significant step toward commercial expansion with the announcement of a new…

Read MoreSunflower Therapeutics Announces Sales Agreement with Optimal Biotech Group